Study Keyword: Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2

The purpose of this study is to assess the efficacy, safety, and tolerability of MK-0472 administered as monotherapy and in combination with pembrolizumab (MK-3475) in participants with histologically or cytologically confirmed diagnosis of advanced/metastatic solid tumors.

There is no primary hypothesis to be tested for this study.